Your browser doesn't support javascript.
loading
Response to azacitidine in patients with chronic myelomonocytic leukemia according to overlap myelodysplastic/myeloproliferative neoplasms criteria.
Triguero, A; Xicoy, B; Zamora, L; Jiménez, M J; García, O; Calabuig, M; Díaz-Beyá, M; Arzuaga, J; Ramos, F; Medina, A; Bernal, T; Talarn, C; Coll, R; Collado, R; Chen, T Hua; Borrás, J; Brunet, S; Marchante, I; Marco, V; López-Cadenas, F; Calbacho, M; Simiele, A; Cortés, M; Cedena, M T; Pedreño, M; Aguilar, C; Pedró, C; Fernández, M; Stoica, C; Ribera, J M; Sanz, G.
Afiliação
  • Triguero A; Hematology Department, Hospital Clinic of Barcelona; Spanish Group of MDS; Universitat Autònoma de Barcelona. Electronic address: atriguero@clinic.cat.
  • Xicoy B; Spanish Group of MDS; Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Badalona; Universitat Autònoma de Barcelona.
  • Zamora L; Spanish Group of MDS; Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Badalona.
  • Jiménez MJ; Spanish Group of MDS; Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Badalona; Universitat Autònoma de Barcelona.
  • García O; Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Badalona.
  • Calabuig M; Spanish Group of MDS.
  • Díaz-Beyá M; Hematology Department, Hospital Clinic of Barcelona; Spanish Group of MDS.
  • Arzuaga J; Spanish Group of MDS.
  • Ramos F; Spanish Group of MDS.
  • Medina A; Spanish Group of MDS.
  • Bernal T; Spanish Group of MDS.
  • Talarn C; Spanish Group of MDS.
  • Coll R; Spanish Group of MDS.
  • Collado R; Spanish Group of MDS.
  • Chen TH; Spanish Group of MDS.
  • Borrás J; Spanish Group of MDS.
  • Brunet S; Spanish Group of MDS.
  • Marchante I; Spanish Group of MDS.
  • Marco V; Spanish Group of MDS.
  • López-Cadenas F; Spanish Group of MDS.
  • Calbacho M; Spanish Group of MDS.
  • Simiele A; Spanish Group of MDS.
  • Cortés M; Spanish Group of MDS.
  • Cedena MT; Spanish Group of MDS.
  • Pedreño M; Spanish Group of MDS.
  • Aguilar C; Spanish Group of MDS.
  • Pedró C; Spanish Group of MDS.
  • Fernández M; Spanish Group of MDS.
  • Stoica C; Spanish Group of MDS.
  • Ribera JM; Hematology Department, Institut Català d'Oncologia-Hospital Germans Trias i Pujol, Josep Carreras Leukemia Research Institute, Badalona; Universitat Autònoma de Barcelona.
  • Sanz G; Spanish Group of MDS.
Leuk Res ; 116: 106836, 2022 05.
Article em En | MEDLINE | ID: mdl-35405632
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mielomonocítica Crônica Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Azacitidina / Leucemia Mielomonocítica Crônica Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article